Voltage-Sensitive Oxonol Dyes Are Novel Large-Conductance Ca2+-Activated K+ Channel Activators Selective for β1 and β4 but Not for β2 Subunits

The large-conductance Ca 2+ -activated K + (BK) channel is activated by both the increase of intracellular Ca 2+ concentration and membrane depolarization. The BK channel plays crucial roles as a key molecule in the negative feedback mechanism regulating membrane excitability and cellular Ca 2+ in v...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmacology Vol. 71; no. 4; p. 1075
Main Authors Takashi Morimoto, Kazuho Sakamoto, Hiroko Sade, Susumu Ohya, Katsuhiko Muraki, Yuji Imaizumi
Format Journal Article
LanguageEnglish
Published American Society for Pharmacology and Experimental Therapeutics 01.04.2007
Online AccessGet full text

Cover

Loading…
Abstract The large-conductance Ca 2+ -activated K + (BK) channel is activated by both the increase of intracellular Ca 2+ concentration and membrane depolarization. The BK channel plays crucial roles as a key molecule in the negative feedback mechanism regulating membrane excitability and cellular Ca 2+ in various cell types. Here, we report that a widely used slow-response voltage-sensitive fluorescent dye, bis(1,3-dibutylbarbituric acid)trimethine oxonol [DiBAC 4 (3)], is a potent BK channel activator. The application of DiBAC 4 (3) at concentrations of 10 nM and higher significantly increased whole-cell BK channel currents in human embryonic kidney 293 cells expressing rat BK channel α and β1 subunits (rBKαβ1). In the presence of 300 nM DiBAC 4 (3), the activation voltage of the BK channel current shifted to the negative direction by approximately 30 mV, but the single-channel conductance was not affected. DiBAC 4 (3) activated whole-cell rBKαβ1 and rBKαβ4 currents in the same concentration range but partially blocked rBKαβ2 currents. The BK channel α subunit alone and some other types of K + channels examined were not markedly affected by 1 μM DiBAC 4 (3). Structure-activity relationship analyses revealed that a set of oxo- and oxoanion-moieties in two 1,3-dialkylbarbituric acids, which are conjugated by oligomethine, is the novel skeleton for the β-subunit-selective BK channel-opening property of DiBAC 4 (3) and related oxonol compounds. This conjugated structure may be located stereochemically in one plane. These findings provide a molecular and structural basis for understanding the regulatory mechanism of BK channel activity by an auxiliary β subunit and will be fundamental to the development of β-selective BK channel openers.
AbstractList The large-conductance Ca 2+ -activated K + (BK) channel is activated by both the increase of intracellular Ca 2+ concentration and membrane depolarization. The BK channel plays crucial roles as a key molecule in the negative feedback mechanism regulating membrane excitability and cellular Ca 2+ in various cell types. Here, we report that a widely used slow-response voltage-sensitive fluorescent dye, bis(1,3-dibutylbarbituric acid)trimethine oxonol [DiBAC 4 (3)], is a potent BK channel activator. The application of DiBAC 4 (3) at concentrations of 10 nM and higher significantly increased whole-cell BK channel currents in human embryonic kidney 293 cells expressing rat BK channel α and β1 subunits (rBKαβ1). In the presence of 300 nM DiBAC 4 (3), the activation voltage of the BK channel current shifted to the negative direction by approximately 30 mV, but the single-channel conductance was not affected. DiBAC 4 (3) activated whole-cell rBKαβ1 and rBKαβ4 currents in the same concentration range but partially blocked rBKαβ2 currents. The BK channel α subunit alone and some other types of K + channels examined were not markedly affected by 1 μM DiBAC 4 (3). Structure-activity relationship analyses revealed that a set of oxo- and oxoanion-moieties in two 1,3-dialkylbarbituric acids, which are conjugated by oligomethine, is the novel skeleton for the β-subunit-selective BK channel-opening property of DiBAC 4 (3) and related oxonol compounds. This conjugated structure may be located stereochemically in one plane. These findings provide a molecular and structural basis for understanding the regulatory mechanism of BK channel activity by an auxiliary β subunit and will be fundamental to the development of β-selective BK channel openers.
Author Hiroko Sade
Susumu Ohya
Katsuhiko Muraki
Takashi Morimoto
Kazuho Sakamoto
Yuji Imaizumi
Author_xml – sequence: 1
  fullname: Takashi Morimoto
– sequence: 2
  fullname: Kazuho Sakamoto
– sequence: 3
  fullname: Hiroko Sade
– sequence: 4
  fullname: Susumu Ohya
– sequence: 5
  fullname: Katsuhiko Muraki
– sequence: 6
  fullname: Yuji Imaizumi
BookMark eNqNjL9OwzAYxC1URFtgZf4mlirBn5s_7VgFEBIIhiDEFrnJ1yTItZHtFPoSrLwHjwAvRlRVzEx3uvvdjdlAG02MnSEPEUV0sTYqRJ6EfIoYJQdshLHAgCPigI04F0kwm8fPQzZ27oVzjOIZP2JDTAWfo8AR-3wyysuagpy0a327IXh4N9oouNySg4UluDcbUnAnbU9lRldd6aUuCTIpJsGi7DfSUwW3E8gaqXXP7kNjHeSkqNzdroyFn4_vLwSpq52LYNn5_t7_dQLybtnp1rsTdriSytHpXo_Z-fXVY3YTNG3dvLWWitdG2rUsjTL1tkixiArkaTz9N_gLrLFnRA
ContentType Journal Article
DOI 10.1124/mol.106.031146
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0111
ExternalDocumentID 71_4_1075
GroupedDBID -
08R
0R
123
2WC
34G
39C
4.4
53G
55
5RE
5VS
AALRV
AAPBV
ABFLS
ABSGY
ABZEH
ACGFS
ADACO
ADBIT
ADCOW
AENEX
AFFNX
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DL
E3Z
EBS
EJD
F5P
FH7
GX1
H13
HH5
HZ
IH2
INIJC
KQ8
L7B
N9A
O0-
O9-
OK1
P2P
R.V
R0Z
RHF
RHI
RPT
WOQ
X
X7M
ZA5
ID FETCH-highwire_pharmacology_71_4_10753
ISSN 0026-895X
IngestDate Tue Jan 05 21:17:30 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-highwire_pharmacology_71_4_10753
PMID 17209121
ParticipantIDs highwire_pharmacology_71_4_1075
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20070401
PublicationDateYYYYMMDD 2007-04-01
PublicationDate_xml – month: 04
  year: 2007
  text: 20070401
  day: 01
PublicationDecade 2000
PublicationTitle Molecular pharmacology
PublicationYear 2007
Publisher American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: American Society for Pharmacology and Experimental Therapeutics
SSID ssj0014580
Score 3.7486303
Snippet The large-conductance Ca 2+ -activated K + (BK) channel is activated by both the increase of intracellular Ca 2+ concentration and membrane depolarization. The...
SourceID highwire
SourceType Publisher
StartPage 1075
Title Voltage-Sensitive Oxonol Dyes Are Novel Large-Conductance Ca2+-Activated K+ Channel Activators Selective for β1 and β4 but Not for β2 Subunits
URI http://molpharm.aspetjournals.org/content/71/4/1075.abstract
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWS9NJL0RXdM4faF0WpRFO2fHQMt0aDJAXsFr4ZWpEgiRgoUhDnI3rtf_QT2h_rDEVLdB0gbS-CRBHc5mE4HM7C2DsR-oHn4ukk7UWxLSIntf3Uc-046Thp6nciR5Cj8MFhd_xFfJp5s43NbcNqqSzC3ejmVr-S_6EqliFdyUv2HyhbN4oF-I70xSdSGJ9_ReOv8qxAfmBPyApd2QAdXctMIiNbJJfWIE-sQ3mVkKY6x1pDmVFwV-UjMAx4i-_Zg0hlN0Ohcx8_latBhvV1MeXhmag8OcvY4HSt7o9aQ97a4666dzBLhBWWBXZZrNXlxKBK5B6XpjB8sEzNa100AbRrFf80OKVET8h1csKTrLeG4KY8ltYEf5vF45NcnlJxXEN1UiIxSuvoeBGsKDd6hk1M409AjM4wYf1sDEnNdGTmQpg2bmumthOPmrbf92bVtqd5PSdNiub1ejOo8sFo0AuDs-Mx2bt9y-ECcXIuz3ZdutjquFqnauDv4lwBEGVFlM4qh_DVyN9_7Mi1nWTPnYs59bzJ7nHkpMTCP85qGyZXeH7lY6Vnp6OS4pDerw6IYuPq3o1I2IYkNX3IHugjEAwqPD9iG0n2mLX1ei92wFzbHWiDSYkn7Psa6KECPRDosdUEFOhhDfSAoLcayMO-BRrw0AAeasADogB-ffv5wwUkv3oTgADH5ov6H4clsJ-y9ofRdDi2l9Oem6Ce12vceca2Mpklzxl0u0nspC7KrlEsAoHbXur1oyAiM1we9p0XbPuOxl7eWeMVu98g_jXbKvIyeYMCbhG-VUT-DZCtsE4
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Voltage-Sensitive+Oxonol+Dyes+Are+Novel+Large-Conductance+Ca2%2B-Activated+K%2B+Channel+Activators+Selective+for+%C3%8E%C2%B21+and+%C3%8E%C2%B24+but+Not+for+%C3%8E%C2%B22+Subunits&rft.jtitle=Molecular+pharmacology&rft.au=Takashi+Morimoto&rft.au=Kazuho+Sakamoto&rft.au=Hiroko+Sade&rft.au=Susumu+Ohya&rft.date=2007-04-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0026-895X&rft.eissn=1521-0111&rft.volume=71&rft.issue=4&rft.spage=1075&rft_id=info:doi/10.1124%2Fmol.106.031146&rft_id=info%3Apmid%2F17209121&rft.externalDBID=n%2Fa&rft.externalDocID=71_4_1075
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0026-895X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0026-895X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0026-895X&client=summon